We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IRB:NSEIRB Infrastructure Developers Limited Analysis

Data as of 2026-03-16 - not real-time

₹41.36

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

IRB trades at ₹41.36, just above its near‑term support of ₹38.30, suggesting limited downside cushion. The 20‑day SMA sits slightly below the current price while the 50‑day and 200‑day SMAs remain higher, reinforcing a short‑term bearish bias. RSI hovers around the 50 mark, indicating a neutral momentum environment. MACD shows a modest bullish histogram despite a negative line‑signal spread, hinting at a possible early reversal. Volume has been trending upward, supporting the price move. Volatility over the past month exceeds 28 % while beta is exceptionally low, meaning price swings are large but largely independent of market moves.
Fundamentals reveal a 16 % revenue contraction year‑over‑year, yet operating margins stay robust at roughly 24 %. Net profit rose 14 % YoY, driven by cost efficiencies, and EPS is projected to climb from 1.27 to 1.87. The stock’s trailing P/E of 32.6 is above the industry average, suggesting a degree of overvaluation, but a forward P/E near 22 signals expected earnings acceleration. Debt levels are high, with a debt‑to‑equity ratio above 100 %, though cash holdings are modest and the dividend payout sits under 20 %, making the current dividend sustainable. Analyst consensus targets imply upside of roughly 30‑40 % and market sentiment is in “Extreme Greed” territory. Taken together, the blend of improving profitability, modest growth prospects, and elevated valuation risk points to a cautious but potentially rewarding investment horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price hovering just above key support
  • high short‑term volatility
  • recent profit growth despite revenue decline

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward earnings expansion and lower forward P/E
  • analyst price targets indicating substantial upside
  • stable dividend payout with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • long‑run infrastructure demand in India
  • low beta suggesting limited market‑wide correlation
  • sustainable dividend and cash generation potential

Key Metrics & Analysis

Financial Health

Revenue Growth-16.30%
Profit Margin11.57%
P/E Ratio32.6
Debt/Equity102.31
P/B Ratio1.2
Industry P/E29.3

Technical Analysis

TrendBearish
RSI49.0
Support₹38.30
Resistance₹44.00
MA 20₹41.22
MA 50₹41.58
MA 200₹44.14
MACDBullish
VolumeIncreasing
Fear & Greed Index79.32

Valuation

Target Price₹57.60
Upside/Downside39.26%
GradeFair
TypeBlend
Dividend Yield0.67%

Risk Assessment

Beta0.18
Volatility28.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.